Stomach surgery without incisions may reverse severe liver damage in obese patients
NCT ID NCT04820036
First seen Jan 08, 2026 · Last updated May 22, 2026 · Updated 25 times
Summary
This study looks at whether endoscopic sleeve gastroplasty (ESG), a procedure that makes the stomach smaller using a flexible tube through the mouth, can improve liver health in 20 adults with obesity and advanced NASH (a severe fatty liver disease with scarring). Researchers will measure changes in liver function, scarring, and pressure in the liver's blood vessels over 12 months. The goal is to see if weight loss from ESG can control or reverse liver damage, but participants may still need ongoing care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.